C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
Quick Stats
Jan 30, 202651.9
AI Score
HOLD1.21
Volume Ratio
Feb 26, 2026
Next Earnings
12
+ve Days (30d)
17
-ve Days (30d)
CCCC Stock Summary
Last updated Jan 30, 2026
CCCC is currently trading at $1.9, positioned below its 200-day moving average of $2.12, suggesting bearish momentum. The stock has a 52-week range of $1.085 to $3.84.
Technical Analysis: The 50-day moving average stands at $2.26, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.523, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.154, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CCCC at 51.9/100 with a HOLD recommendation.
CCCC (C4 Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.523 |
| CMF (20) | 0.154 |
| ROC (10) | -14.414 |
| ADX (14) | 15.356 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.059 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -89.062 |
| MFI (14) | 17.687 |
CCCC Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CCCC Price vs Max Options Open Interest
CCCC Max Change In Options Open Interest
CCCC Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CCCC Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CCCC Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CCCC Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
C4 Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CCCC Moving Averages Analysis
CCCC (C4 Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.1 |
| 20 | 2.13 |
| 30 | 2.09 |
| 50 | 2.26 |
| 100 | 2.38 |
| 200 | 2.12 |
CCCC Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 190.0 million |
| Earnings/Share ($) | -1.67 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.52 |
| EPS Estimate Next Year ($) | -1.2867 |
| WallStreet Target Price ($) | 9.8571 |
| Most Recent Quarter |